ACM
GOSS icon

Altium Capital Management’s Gossamer Bio GOSS Stock Holding History

Altium Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,688
Closed -$1.62M – 109
2022
Q3 		$1.62M Sell
1,688
-1,562
-48% -$1.55M 0.59% 68
2022
Q2 		$2.18M Buy
+3,250
New +$2.01M 0.87% 47

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Altium Capital Management's GOSS Position: Q4 2022 in Review

Altium Capital Management sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 1,688 shares — an estimated $1.62M sold.

Altium Capital Management first reported a position in GOSS in Q2 2022 and held it in 2 quarters. The position peaked at $2.18M in Q2 2022. 118 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Altium Capital Management reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Altium Capital Management sold 1,688 Gossamer Bio shares in Q4 2022, an estimated $1.62M.
  • Altium Capital Management first reported a position in Gossamer Bio in Q2 2022 and held it in 2 quarters.
  • Altium Capital Management's Gossamer Bio position peaked at $2.18M in Q2 2022.
  • 118 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Altium Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.